Crossmark

Ameliorative effects of agomelatine against doxorubicin-induced hepatotoxicity

Crossref DOI link: https://doi.org/10.1186/s40360-025-00988-y

Published Online: 2025-08-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Savas, Hasan Basri https://orcid.org/0000-0001-8759-4507
Sozen, Mehmet Enes https://orcid.org/0000-0002-5007-6631
Cuce, Gokhan https://orcid.org/0000-0003-1781-5292
Batur, Tuba https://orcid.org/0000-0002-8225-3153
License Information

Text and Data Mining valid from 2025-08-08

Version of Record valid from 2025-08-08
More Information

Article History

Received: 2 July 2025

Accepted: 6 August 2025

First Online: 8 August 2025

Declarations

:

: The authors declare no competing interests.